γ-secretase Deficient E-Cre-ERT2 Stable Expressing Rat1 (AD6 Clone 1) Cell Line

Unit

1×10⁶ cells / 1 ml

Cell Type

Stable (KO/Expressing) Cells

Tissue Type

Embryo

Organism

Rat (R. norvegicus)

Donor History
Growth Properties

Adherent

,

fibroblast

Growth Conditions

PriCoat™ T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) are recommended for optimal cell culture. Dulbecco's Modified Eagle Medium (DMEM)

,

High Glucose (TM500) + 10% FBS + 1% Penicillin/Streptomycin Solution (G255)

,

37.0°C

,

5% CO₂. 1.0 mg/ml Hygromycin (G265)

,

10 µg/ml Blasticidin

,

4 mg/ml Geneticin/G418 (G271) and 10-6 M tamoxifen for selection. Note: Selection drugs should be added to the culture medium after the first passage to ensure cells have recovered from freeze-thaw conditions.

Immortalization Method
Full Information

https://www.abmgood.com/gamma-secretase-deficient-e-cre-ert2-stable-expressing-rat1-ad6-clone-1-cell-line.html

Katalogové číslo: T6170 Kategorie: ,
Popis

This rat cell line expresses a chimeric molecule containing a delta E-like fragment of Notch1 fused to a vesicular stomatitis virus epitope the Cre recombinase and a modified hormone binding domain of the estrogen receptor. The delivery of Cre recombinase depends on any event including gamma-secretase processing that releases the intracellular domain of Notch1 from the membrane. Nuclear activity of the Cre-ER-T2 chimera depends on the presence of tamoxifen. This cell line was derived from clones deficient in gamma-secretase activity thus displaying impaired activity on Notch. Reporter construct for the recombinase activity consists of an antibiotic resistance gene (hygromycin). This cell line would be well-suited for research regarding the functions of the Notch receptor gamma-secretase enzyme activity and their involvement in cellular signalling.

O značce
Applied Biological Materials (abm) je jedním z našich klíčových dodavatelů pro biotechnologický průmysl. Společnost byla založena v roce 2004 a již více než deset let podporuje vědecké objevy v oblasti přírodních věd a vývoje léčiv. Její sídlo se nachází ve Vancouveru v Kanadě. ABM je pro nás neocenitelným partnerem zejména v  oblasti dodávek buněčných kultur, genových a virových vektorů, produktů pro molekulární biologii a PCR, nástrojů pro technologie CRISPR a RNAi, protilátek i základních reagencií pro molekulárně genetické procesy.